The UK government is to provide £30 million from its Industrial Strategy Challenge Fund to support industry-academia partnerships to develop advanced therapies for a range of diseases.
Researchers, businesses and NHS trusts are invited to apply for a share of the funding to set up centres to treat forms of blindness, cancer, heart failure, liver disease, neurological conditions and paediatric diseases, Innovate UK announced on 2 October.
The announcement follows chief medical officer Sally Davies’ call to make genomic studies an integral part of all efforts to develop novel medical treatments. The Cell and Gene Therapy Catapult will co-ordinate the activities of the proposed partnerships.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.